Finny logo
Finny logo

7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15/month, without ads. Start a trial. Go ad free!

BBH vs ARKG

Both ARKG and BBH are ETFs. ARKG has a higher 5-year return than BBH (45.99% vs 11.13%). ARKG has a higher expense ratio than BBH (0.75% vs 0.35%). Below is the comparison between ARKG and BBH.

ARKG BBH
Segment Equity: Global Biotech Equity: Global Biotech
Issuer ARK VanEck
Net Assets $7.65B $478.8M
Expense Ratio 0.75% 0.35%
Management Style active passive (index-based)
Dividend Yield 0.85% 0.36%
Underlying Index -- MVIS US Listed Biotech 25 Index
YTD Return 15.76% 6.65%
1-Year Return 209.63% 29.43%
3-Year Return 64.53% 12.34%
5-Year Return 45.99% 11.13%
10-Year Return N/A N/A

ARKG description

The Fund seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary.

ARKG performance & returns

YTD Return 15.76%
1-Month Return 14.98%
3-Month Return 49.30%
1-Year Return 209.63%
3-Year Return 64.53%
5-Year Return 45.99%
10-Year Return N/A
ARKG expense ratio is 0.75%.

ARKG holdings

Top 10 Holdings (52.77% of Total Assets)

Name Symbol % Assets
Invitae Corp NVTA 8.84%
CRISPR Therapeutics AG CRSP 8.44%
Pacific Biosciences of California Inc PACB 7.19%
Arcturus Therapeutics Holdings Inc ARCT 5.75%
Twist Bioscience Corp TWST 4.61%
CareDx Inc CDNA 3.89%
Iovance Biotherapeutics Inc IOVA 3.76%
Personalis Inc PSNL 3.50%
Exact Sciences Corp EXAS 3.41%
Seres Therapeutics Inc MCRB 3.38%

Other relevant ARKG comparisons

You may also want to check out the following ARKG comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

BBH description

The Fund seeks to replicate the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The Index is comprised of common stocks and depository receipts of US exchange-listed companies in biotechnology sector.

BBH performance & returns

YTD Return 6.65%
1-Month Return 3.82%
3-Month Return 11.59%
1-Year Return 29.43%
3-Year Return 12.34%
5-Year Return 11.13%
10-Year Return N/A
BBH expense ratio is 0.35%.

BBH holdings

Top 10 Holdings (61.45% of Total Assets)

Name Symbol % Assets
Amgen Inc AMGN 14.27%
Gilead Sciences Inc GILD 7.23%
Moderna Inc MRNA 5.48%
Regeneron Pharmaceuticals Inc REGN 5.47%
Exact Sciences Corp EXAS 5.28%
Alexion Pharmaceuticals Inc ALXN 4.92%
IQVIA Holdings Inc IQV 4.91%
Biogen Inc BIIB 4.75%
Vertex Pharmaceuticals Inc VRTX 4.59%
Illumina Inc ILMN 4.55%

Other relevant BBH comparisons

You may also want to check out the following BBH comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
Follow Us